# Kesios Therapeutics: Biotechnology, London, United Kingdom

> Kesios Therapeutics: Kesios Therapeutics Limited was a private biotechnology company established in 2012 as a spin-out from Imperial College London.

Source: https://millionrounds.com/startup/kesios-therapeutics (Millionrounds; every figure on the page links to its filing or article)

United Kingdom · [Biotechnology startup](https://millionrounds.com/companies)

# Kesios Therapeutics

Kesios Therapeutics Limited was a private biotechnology company established in 2012 as a spin-out from Imperial College London.

Funding reported Last round: Debt financing

Biotechnology London, United Kingdom

Company summary

- **Founded:** 2012 14 years old
- **Team:** 1 1 to 10 people
- **Funding reported:** 20.9M as listed, currency not stated
- **Last round:** Debt financing Aug 2016

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Kesios Therapeutics has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Kesios Therapeutics

Kesios Therapeutics Limited was a private biotechnology company established in 2012 as a spin-out from Imperial College London.

The company focused on the research and development of small molecule drugs aimed at treating haematological malignancies, particularly multiple myeloma and diffuse large B-cell lymphoma. Its lead candidate, KES-0001, was a GADD45B inhibitor targeting the NF-κB pathway, which is crucial for cancer cell survival. Kesios raised £19 million in a Series A financing round to support its research efforts. Despite advancing its lead candidate toward clinical development, the company faced challenges in replicating pre-clinical assays, which led to the suspension of further development work. Kesios Therapeutics was officially dissolved on February 28, 2024, ceasing all operations.

## What company datasets say Kesios Therapeutics raised

Funding, as reported

Reported in all **20.9M** in the source's currency

Rounds **3**

Last round **Debt financing**

Last round size **29.7M**

Last round date **Aug 2016**

Investors listed **3**

## Biotechnology in United Kingdom

Startups like it

- [**CellCentric** Saffron Walden · founded 2004 *Raised*](https://millionrounds.com/company/cellcentric)
- [**Oxford BioTherapeutics** Oxford · founded 2004 *Raised*](https://millionrounds.com/company/oxford-biotherapeutics)
- [**Chroma Therapeutics** Milton · founded 2020](https://millionrounds.com/startup/chroma-therapeutics)
- [**Oxagen** Abingdon · founded 1996](https://millionrounds.com/startup/oxagen)
- [**RQ Biotechnology Ltd.** London · founded 2022](https://millionrounds.com/startup/rq-biotechnology-ltd)
- [**ONI** Oxford · founded 2016](https://millionrounds.com/startup/oni-2)
- [**Oxular** Oxford · founded 2014](https://millionrounds.com/startup/oxular)
- [**Maxion Therapeutics** Cambridge · founded 2020](https://millionrounds.com/startup/maxion-therapeutics)

## Is this your company?

Add your raise, your deck and your story, and put Kesios Therapeutics in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)